CLINUVEL

SCENESSE

Manufacturer:

CLINUVEL

Scenesse HCPCS:

J7352

HCPCS Code Descriptor:

Afamelanotide implant, 1 mg

Category:

J Code

Scenesse NDCs:

Primary Type:

MC1-R agonist

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Scenesse:

SCENESSE is a MC1-R agonist drug manufactured by CLINUVEL and administered via the Subcutaneous route of administration. The J Code: J7352 is aligned to the drug SCENESSE.

SCENESSE is a member of the class of drugs known as melanocortin agonists and is often used to increase tolerance to the sun and light. SCENESSE is manufactured by Clinuvel Pharmaceuticals and is aligned to the HCPCS code J7352. It has been aligned to this HCPCS code since January 2021.

ACCESS PRICING AND MORE BY REGISTERING

J7352 Added Date:

January 1, 2021

J7352 Effective Date:

January 1, 2021

J7352 Termination Date:

HCPCS Active

Scenesse billing and coding information can be found through Clinuvel at the link below:
Scenesse patient assistance information can be found through Clinuvel Pharmaceuticals at the URL: https://scenesse.com/hcp/savingsprogram-hcp/
SCENESSE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for SCENESSE. Please check back in a few weeks.